Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential

Life Science

It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks

Life Science

BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain

Life Science

Why Can Eli Lilly Ignore Tariff Threats? Domestic Production Capacity and Gene Therapy Are Key

Life Science

Medical Device Stocks and ETFs in Focus as Market Set to Top $1 Trillion

Life Science

Navigating the Low Point: Can Moderna’s Innovative Pipeline Illuminate the Path Forward?

Life Science

Healthcare Services Group’s Earnings Soar, Stock Price Surges Nearly 14% in a Single Day

Life Science

Intuitive Surgical Soars 16% as da Vinci Demand and Robust Earnings Beat Expectations

Life Science, Technology

Nvidia-Backed AI Biotech Recursion Soars 25% in a Month: Time to Buy or Beware?

Life Science

From AI Finance to Smart Healthcare: Unveiling Cathie Wood’s Three Top Investment Directions Right Now

Life Science, Technology

Goldman’s 2026 Playbook: Ride Dividend Growth in Healthcare, Utilities, Industrials

Energy, Life Science

Tempus AI Stock Lifted by Analyst Optimism and Subsidiary’s Tech Breakthrough

Life Science, Technology

Why Should We Pay Attention to Temporarily Setback-Stricken Novo Nordisk and Merck?

Life Science

Seeking Reliable Income? Top Picks in High-Yield Healthcare Stocks

Life Science

Who Will Dominate the Next Generation of Weight-Loss Drugs? The Fierce Battle Between Eli Lilly and Viking

Life Science